ロード中...

Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritis.

In a randomised, placebo controlled, double blind study inosine pranobex was assessed as a possible second line drug in rheumatoid arthritis. Twenty four patients received inosine pranobex (3 g/day) and 26 patients received placebo for up to 24 weeks. Morning stiffness, articular index, grip strengt...

詳細記述

保存先:
書誌詳細
主要な著者: Brzeski, M, Madhok, R, Hunter, J A, Capell, H A
フォーマット: Artigo
言語:Inglês
出版事項: 1990
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC1004071/
https://ncbi.nlm.nih.gov/pubmed/1693065
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!